Jubilant Pharmova Ltd, Nanjangud Plant has optimised water conservation and ZLD (Zero Liquid Discharge) objectives on a sustainable basis by implementing unique, revolutionary , sustainable, “SCALEBAN ” technology by minimising load on costly conventional technologies like RO & MEE.
Jubilant Pharma Limited is a global integrated pharmaceutical company offering a wide range of products and services to their customers across geographies. Jubilant has its pharma business into three segments i.e.
‘Specialty Pharmaceuticals’ comprising Radiopharmaceuticals (including Radiopharmacies) and allergy therapy products.
High operating cost of existing ZLD system was the concern for Jubilant
Jubilant came across ‘SCALEBAN’ Technology through their industrial references/ interactions with our existing clients, to gain further confidence on our non conventional ‘SCALEBAN’ technology, Jubilant team visited few of our client sites. After verifying the performance of “SCALEBAN” technology, Jubilant implemented ‘SCALEBAN’ technology to utilize their 100m3/day wastewater in MEE cooling tower in place of fresh treated water at high COC for optimizing water conservation and ZLD (zero liquid discharge) objectives on a sustainable basis.
After successful operation of the ‘SCALEBAN’ project, Jubilant awarded repeat order to implement ‘SCALEBAN’ technology at their another facility i.e. Jubilant Ingrevia Ltd at Gajraula (UP), India to utilize 150m3/day wastewater at pyridine plant cooling tower.
In ‘SCALEBAN’ process at Jubilant, Nanjangud, we are using 100 m3/day RO reject water (MEE feed) in cooling tower at very high COC (15-20) and saved high operating cost of MEE (Evaporator).
We are thankful to JUBILANT group for implementing “SCALEBAN” Technology for achieving water conservation and ZLD system.
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.